Claritas Announces Option to Acquire Rights to Novel Drug for Treatment of COVID-19 Related ARDS

NEXT STORY
Zai Lab Expands U.S. Operations to Join the Cambridge Biotechnology Community
PREV STORY
OncXerna Therapeutics Announces New Phase 2 and Biomarker Data in Gastric Cancer from Bavituximab Program at the ESMO Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Green Lobster CBD Gummies Review: Pure Hemp Neon Cubes That Work?

author_avatar
NASDAQ Market News

First nine months of the year with 1% sales growth at constant exchange rates, significant impact of COVID-19 pandemic

author_avatar
NASDAQ Market News

HIV Testing Market, 2022 – Focus on Lab-based Immunoassay, Molecular & Point-of-care (POC) HIV Testing

Dublin, Nov. 16, 2017 (GLOBE NEWSWIRE) -- The "HIV Testing Market (Immunoassay, Molecular, Point-of-Care ...

author_avatar
NASDAQ Market News